Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06052137 · ClinicalTrials.gov registry record · NA

Open Label - Personalized Therapeutic Neuromodulation for Anhedonic Depression

A NA study of Treatment-Resistant Depression, sponsored by Stanford University.

Active
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT06052137 is a NA study of Treatment-Resistant Depression that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 16 participants, below the 374-participant average among 54 other Treatment-Resistant Depression trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06052137, a NA study of Treatment-Resistant Depression, is active but no longer recruiting, sponsored by Stanford University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

This study will investigate the anti-anhedonic efficacy of a novel neurostimulation strategy termed accelerated intermittent theta burst stimulation (aiTBS) in participants with treatment resistant depression (TRD).

Conditions Studied

Treatment-Resistant Depression

Interventions

  • DEVICE Active TBS-DLPFC
  • DEVICE TBS-DMPFC

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2023-12-19
Est. Completion 2025-10
Phase NA

Sponsor

Stanford University

1,744 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06052137

The ClinicalTrials.gov registry entry for NCT06052137 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 374-participant average among 54 other Treatment-Resistant Depression trials with a reported enrollment target (96% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Treatment-Resistant Depression appearing as the primary indexed condition, and to 2 interventions - of which Active TBS-DLPFC is the first listed.

NCT06052137 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06052137 about?

NCT06052137 is a clinical study titled "Open Label - Personalized Therapeutic Neuromodulation for Anhedonic Depression". This study will investigate the anti-anhedonic efficacy of a novel neurostimulation strategy termed accelerated intermittent theta burst stimulation (aiTBS) in participants with treatment resistant depression (TRD).

What is the current status of trial NCT06052137?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2023-12-19. Estimated completion is 2025-10.

What conditions does trial NCT06052137 study?

This clinical trial studies the following conditions: Treatment-Resistant Depression.

What interventions are being tested in trial NCT06052137?

The interventions under investigation include: Active TBS-DLPFC (DEVICE), TBS-DMPFC (DEVICE).

Who is sponsoring clinical trial NCT06052137?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06052137 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Treatment-Resistant Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Treatment-Resistant Depression

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.